A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Clinical trial NCT04424316 · COMPLETED

Trial details

NCT number: NCT04424316
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Tract Infection

Start date: 2020-06-17
Primary completion: 2023-10-27
Enrollment: 14727

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.